首页> 外文OA文献 >PCN63 Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: A Patient Level Simulation Model

【2h】

PCN63 Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: A Patient Level Simulation Model

机译：英国人群为基础的人群中弥漫性大B细胞淋巴瘤的PCN63成本昂贵的治疗途径：患者水平模拟模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wang H.I.; Smith A.; Roman E.; Crouch S.; Jack A.; Patmore R.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: A population-based cohort study on treatment, toxicity and outcome [J] . BoslooperK., KibbelaarR., StormH., Leukemia and lymphoma . 2014,第3期

机译：利妥昔单抗，环磷酰胺，阿霉素，长春新碱和泼尼松龙治疗对老年弥漫性大B细胞淋巴瘤患者是有益的但有毒性：基于人群的治疗，毒性和预后队列研究
2. Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada. [J] . Johnston KM, Marra CA, Connors JM, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2010,第6期

机译：在加拿大不列颠哥伦比亚省一个以人群为基础的观察性队列中，将利妥昔单抗添加到CHOP化疗中作为一线治疗弥漫性大B细胞淋巴瘤的一线治疗的成本效益。
3. Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study [J] . Juul Maja Bech, Jensen Pernille Hammershoej, Engberg Henriette, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：75岁或以上的1011名患者弥漫性大B细胞淋巴瘤的治疗策略和结果：丹麦人口群体研究
4. Survival Prediction in Patients with Diffuse Large B-cell Lymphoma Using Logistic and Neural Network Models [C] . Chin-Chuan Chang, Chien-Hua Chen, Jer-Guang Hsieh, IEEE Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability . 2021

机译：逻辑和神经网络模型弥漫性大B细胞淋巴瘤患者的存活预测
5. Clinical outcomes and cost-effectiveness of white blood cell growth factors in elderly patients with non -Hodgkin's lymphoma: Findings from a large population-based cohort. [D] . Gruschkus, Stephen K. 2009

机译：非霍奇金淋巴瘤的老年患者的白细胞生长因子的临床结果和成本效益：基于大量人群的研究结果。
6. Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort [O] . Han-I. Wang, Alexandra Smith, Eline Aas, -1

机译：弥漫性大B细胞淋巴瘤（DLBCL）的治疗费用和预期寿命：基于英国人群的观察性队列的离散事件模拟模型
7. Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort [O] . Han-I. Wang, Alexandra Smith, Eline Aas, 2016

机译：弥漫性大B细胞淋巴瘤（DLBCL）的治疗费用和预期寿命：基于英国人群的观察性队列的离散事件模拟模型

PCN63 Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: A Patient Level Simulation Model

著录项

引文网络

相似文献

相关主题

期刊订阅